Biofilm Formation: How Bacterial Adhesins Drive Surface Colonization

Biofilms — structured communities of bacteria encased in a self-produced extracellular matrix — represent the predominant mode of bacterial existence in most natural and clinical environments. They are responsible for the majority of persistent and device-related bacterial infections, and their extraordinary tolerance to antibiotics and host immune responses makes them among the most difficult clinical challenges in infectious disease. The process begins with adhesion, making adhesins the molecular trigger that initiates the entire biofilm developmental cascade.

Initial Reversible and Irreversible Attachment

Biofilm formation proceeds through distinct stages, beginning with reversible physical contact between a free-floating planktonic bacterium and a surface. At this stage, non-specific van der Waals forces, electrostatic interactions, and hydrophobic effects bring bacteria within nanometer range of the surface. Adhesins then mediate specific, high-affinity bonds to surface-associated receptors or conditioning films of host proteins (fibronectin, fibrinogen, vitronectin) that coat implanted medical devices within minutes of placement. These initial adhesin-receptor bonds convert reversible contact into irreversible attachment. For Staphylococcus epidermidis — the leading cause of implant-associated infections — surface protein SdrF binds collagen, and AtlE autolysin promotes attachment to polystyrene through hydrophobic interaction. The transition from reversible to irreversible attachment is the key commitment point: once achieved, bacteria begin expressing biofilm-specific genetic programs.

Extracellular Matrix Elaboration and Microcolony Development

Following surface commitment, adhered bacteria upregulate production of extracellular polymeric substances (EPS) through quorum sensing signals and biofilm-specific gene regulators such as the ica operon (encoding poly-N-acetylglucosamine) in staphylococci and pel and psl loci in Pseudomonas aeruginosa. The EPS matrix creates a highly hydrated, structured scaffold that protects embedded cells from desiccation, antibiotics, and phagocytic attack. Within this developing microcolony, bacteria differentiate phenotypically — surface-attached cells express adhesin-encoding genes at far higher levels than their planktonic counterparts, reinforcing attachment as the population grows. Extracellular DNA (eDNA), released by autolysis of a subpopulation of bacteria, contributes to matrix stability and serves as a surface for further cell attachment. The mature biofilm architecture includes water channels that distribute nutrients and remove metabolic waste, functioning as a primitive vascular system.

Antibiotic Tolerance Mechanisms in Biofilms

The antibiotic tolerance of biofilm bacteria — often 10–1000-fold greater than planktonic cells of the same strain — has multiple mechanistic bases, all of which depend on the structural and physiological changes initiated by surface adhesion. The EPS matrix physically retards antibiotic penetration, particularly for positively charged aminoglycosides that bind to negatively charged matrix components. Nutrient gradients within the biofilm produce metabolically dormant "persister" subpopulations deep in the biofilm core that survive antibiotic exposure because many antibiotics target active metabolic processes. Biofilm-specific gene expression programs upregulate efflux pumps and stress response genes. The high cell density within biofilms also facilitates horizontal gene transfer of antibiotic resistance plasmids and transposons between neighboring cells. These compounded mechanisms explain why infected prosthetic joints, central venous catheters, and heart valves typically cannot be sterilized with antibiotics alone and often require surgical removal.

Dispersal, Seeding, and Systemic Infection

Biofilm dispersal — the active release of bacteria from an established biofilm — is a critical but often underappreciated phase of the biofilm lifecycle and a potential trigger for serious systemic infection. Dispersal is triggered by environmental signals including nutrient depletion, shear stress, and specific chemical cues. Bacteria undergo a phenotypic reversion from biofilm to planktonic mode, downregulating adhesin expression and matrix production while upregulating motility and virulence factors adapted to the planktonic lifestyle. Dispersed cells seeding bloodstream or tissue sites carry with them the physiological memory of biofilm-adapted gene expression, potentially contributing to their enhanced ability to re-adhere and establish new biofilm foci at distant sites. In endocarditis, the cyclic process of biofilm growth, dispersal, and embolic seeding drives the classic clinical presentation of fever, bacteremia, and peripheral septic emboli.

Conclusion

Adhesins are the initiating molecular event in a cascade of structural and physiological changes that transform individual bacterial cells into a highly tolerant, persistent community. Blocking this initial adhesion step — before the developmental program is engaged — represents one of the most promising anti-biofilm therapeutic strategies. For more research on biofilm biology and bacterial pathogenesis, visit our homepage or contact our research network.